Is the Ramsay Health Care share price a buy?

The Ramsay Health Care Limited (ASX: RHC) share price has just recovered from hitting its lowest level in four years – is it a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price has just recovered from hitting its lowest level in four years. After reaching an all-time high of $81.31 in September 2016, the share price (and Ramsay shareholders) have been suffering ever since. Ramsay did not come out of the recent correction unscathed, with the sell-off dragging the share price to a four-year low of $52.92 in October. It has since bounced back slightly and at the time of writing, is trading around the $58 mark.

Australia's ageing population and ever-rising demand for medical services bode well for the healthcare sector, which has been one of the strongest performers on the ASX over the past decade. Stocks such as CSL Limited (ASX: CSL) and NIB Holdings Limited (ASX: NHF) have generated stellar returns for investors during this time.

Ramsay is Australia's largest private hospital operator, with over 223 hospitals and more than 60,000 staff across several countries, with a strong and expanding presence in Europe. Ramsay has historically enjoyed strong returns on invested capital due to its ownership and management of flagship private hospitals in Australia, resulting in a reputation for high-quality care. The company's scale also enables them to negotiate very effectively with private health insurers, which gives it enormous pricing power. This has enabled Ramsay to establish a significant cost advantage, which has underpinned its successful expansion both in Australia and overseas.

So, what has gone wrong?

Ramsay is facing some difficult structural problems going into 2019. Analysts are expecting core EPS growth of only 2% for the financial year, mainly due to some recent acquisitions that are not yet bearing fruit. Furthermore, declining private health insurance memberships and high out-of-pocket hospital costs are pushing more patients into the public health system, and out of Ramsay's private hospitals, placing pressure on earnings.

However, Ramsay remains confident of its acquisitions and is planning on expanding their business into more areas into the future.

Foolish takeaway

Although Ramsay is facing some short-term headwinds, I believe the demographics of the healthcare sector, both in Australia and around the globe, provide a significant tailwind for the company. I believe Ramsay's effective management team and expansion strategy make Ramsay Health Care a great addition for any long-term investor.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »